Your browser doesn't support javascript.
loading
Principles for delivering improved care of people with functional seizures: Closing the treatment gap.
Winton-Brown, Toby; Wilson, Sarah J; Felmingham, Kim; Rayner, Genevieve; O'Brien, Terence J; O'Brien, Patrick; Mohan, Adith; Velakoulis, Dennis; Kanaan, Richard.
Afiliação
  • Winton-Brown T; Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia.
  • Wilson SJ; Alfred Mental and Addiction Health, Alfred Health, Melbourne, VIC, Australia.
  • Felmingham K; Melbourne School of Psychological Sciences, The University of Melbourne, Parkville, VIC, Australia.
  • Rayner G; Department of Clinical Neuropsychology and Department of Medicine, Austin Health, Heidelberg, VIC, Australia.
  • O'Brien TJ; Melbourne School of Psychological Sciences, The University of Melbourne, Parkville, VIC, Australia.
  • O'Brien P; Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia.
  • Mohan A; Melbourne School of Psychological Sciences, The University of Melbourne, Parkville, VIC, Australia.
  • Velakoulis D; Department of Neuroscience, Central Clinical School, Monash University, Melbourne, VIC, Australia.
  • Kanaan R; Department of Clinical Neurosciences, St Vincent's Hospital, Fitzroy, VIC, Australia.
Aust N Z J Psychiatry ; 57(12): 1511-1517, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37394954
ABSTRACT
Patients diagnosed with functional (psychogenic nonepileptic) seizures have similar or greater levels of disability, morbidity and mortality than people with epilepsy, but there are far fewer treatment services. In contrast to epilepsy, the current understanding of pathophysiological mechanisms and the development of evidence-based treatments for functional seizures is rudimentary. This leads to high direct healthcare costs and high indirect costs to the patient, family and wider society. There are many patient, clinician and system-level barriers to improving outcomes for functional seizures. At a patient level, these include the heterogeneity of symptoms, diagnostic uncertainty, family factors and difficulty in perceiving psychological aspects of illness and potential benefits of treatment. Clinician-level barriers include sub-specialism, poor knowledge, skills and attitudes and stigma. System-level barriers include the siloed nature of healthcare, the high prevalence of functional seizures and funding models relying on individual medical practitioners. Through the examination of international examples and expert recommendations, several themes emerge that may address some of these barriers. These include (1) stepped care with low-level, brief generalised interventions, proceeding to higher level, extended and individualised treatments; (2) active triage of complexity, acuity and treatment readiness; (3) integrated interdisciplinary teams that individualise formulation, triage, and treatment planning and (4) shared care with primary, emergency and community providers and secondary consultation. Consideration of the application of these principles to the Australian and New Zealand context is proposed as a significant opportunity to meet an urgent need.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Convulsões / Epilepsia Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Oceania Idioma: En Revista: Aust N Z J Psychiatry Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Convulsões / Epilepsia Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Oceania Idioma: En Revista: Aust N Z J Psychiatry Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Austrália